{"id":197087,"date":"2024-10-05T12:23:02","date_gmt":"2024-10-05T17:23:02","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/10\/dr-luba-perry-ph-d-ceo-reconstruct-bio-bioengineered-breast-reconstruction-and-augmentation"},"modified":"2024-10-05T12:23:02","modified_gmt":"2024-10-05T17:23:02","slug":"dr-luba-perry-ph-d-ceo-reconstruct-bio-bioengineered-breast-reconstruction-and-augmentation","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/10\/dr-luba-perry-ph-d-ceo-reconstruct-bio-bioengineered-breast-reconstruction-and-augmentation","title":{"rendered":"Dr. Luba Perry, Ph.D. \u2014 CEO, ReConstruct Bio \u2014 Bioengineered Breast Reconstruction And Augmentation"},"content":{"rendered":"<p><\/p>\n<p><iframe style=\"display: block; margin: 0 auto; width: 100%; aspect-ratio: 4\/3; object-fit: contain;\" src=\"https:\/\/www.youtube.com\/embed\/b0n4aLyx2fU?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope;\n   picture-in-picture\" allowfullscreen><\/iframe><\/p>\n<p>Bioengineered breast reconstruction and augmentation \u2014 dr. luba perry, phd \u2014 CEO, reconstruct bio.<\/p>\n<hr>\n<p>Dr. Luba Perry, Ph.D. is Co-Founder and CEO of ReConstruct Bio (<a href=\"https:\/\/wyss.harvard.edu\/technology\/r\">https:\/\/wyss.harvard.edu\/technology\/r<\/a>\u2026), an innovative venture emerging from Harvard\u2019s Wyss Institute (<a href=\"https:\/\/wyss.harvard.edu\/team\/advance\">https:\/\/wyss.harvard.edu\/team\/advance<\/a>\u2026), aimed at redefining the fields of medical reconstruction and aesthetics with an initial application of their groundbreaking technology on breast reconstruction and augmentation. With a multidisciplinary team of experts, the ReConstruct Bio team has developed the BioImplant\u2014a living, bioengineered tissue created from the patient\u2019s own cells, to provide safer, more natural alternative to current standards, which are often associated with significant drawbacks and health concerns.<\/p>\n<p>Dr. Perry also serves as a Senior Scientist at the Wyss Institute for Biologically Inspired Engineering working at the 3D Organ Engineering Initiative since 2018 and is leading a Wyss Validation Project aiming to fabricate vascularized functional tissues for transplantation. Her interest is in tissue and organ engineering, focusing on vascularization and implantation studies utilizing complex surgical models.<\/p>\n<p>Dr. Perry\u2019s background is in molecular biology, pharmacology, and biomedical engineering, with a Bachelor of Science \u2014 BS, Biology, Master of Science \u2014 MS, Molecular Pharmacology, and a Doctor of Philosophy \u2014 PhD, Biotechnology, all from Technion \u2014 Israel Institute of Technology. She also has industry experience in a vascular gene therapy company (MGVS, now VESSL Therapeutics).<\/p>\n<p>#LubaPerry #Harvard #WyssInstitute #ReConstructBio #Aesthetics #3DOrganEngineering #BreastReconstruction #BreastAugmentation #Vascularization #Innervation #Fat #AdiposeTissue #BreastImplants #Organogenesis #OrganEngineering #TissueEngineering #Bioengineering #Organs #Tissues #MolecularPharmacology #Breasts #Nipples.<\/p>\n<div class=\"more-link-wrapper\"> <a class=\"more-link\" href=\"https:\/\/lifeboat.com\/blog\/2024\/10\/dr-luba-perry-ph-d-ceo-reconstruct-bio-bioengineered-breast-reconstruction-and-augmentation\">Continue reading \u201cDr. Luba Perry, Ph.D. \u2014 CEO, ReConstruct Bio \u2014 Bioengineered Breast Reconstruction And Augmentation\u201d | &gt;<\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bioengineered breast reconstruction and augmentation \u2014 dr. luba perry, phd \u2014 CEO, reconstruct bio. Dr. Luba Perry, Ph.D. is Co-Founder and CEO of ReConstruct Bio (https:\/\/wyss.harvard.edu\/technology\/r\u2026), an innovative venture emerging from Harvard\u2019s Wyss Institute (https:\/\/wyss.harvard.edu\/team\/advance\u2026), aimed at redefining the fields of medical reconstruction and aesthetics with an initial application of their groundbreaking technology on breast [\u2026]<\/p>\n","protected":false},"author":400,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,11,1495],"tags":[],"class_list":["post-197087","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/197087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/400"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=197087"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/197087\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=197087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=197087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=197087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}